Rush University Medical Center Dept.of Rush UniversityMedCtr.
				
				
					1653 West Congress Parkway					
Chicago, Illinois 60612
														
          Chicago, Illinois 60612
We've found
        1 trials
        at this facility
      	
	Hematology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials